Supported by

Tricuspid / Pulmonary valve

Find all the latest content on tricuspid or pulmonary valve published on this website.

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

479 results

TRISCEND II: implications on current clinical practice

09 Sep 2024

Watch the replay of this webinar with J. Dreyfus, A. Duncan, P. Lurz and V. Rudolph to understand the pros and cons of TTVR and much more!

TRISCEND II: implications on current clinical practice

TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE

31 Aug 2024

Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.

Simultaneous publication in European Heart Journal, ehae578

Alessandro Sticchi

Author

Alessandro Sticchi
Benefit of isolated surgical valve repair or replacement for functional TR and long-term outcomes

Structural cardiac interventions in patients with heart failure

27 Aug 2024

The review aims to address the unmet needs in heart failure (HF) management, particularly in patients where structural heart disease coexists with HF and limits the effectiveness of guideline-directed medical therapy (GDMT).

Alessandro Sticchi

Reviewer

Alessandro Sticchi
Structural cardiac interventions in patients with heart failure

TRI.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

31 Aug 2024

Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.

Alessandro Sticchi

Author

Alessandro Sticchi
Tri.fr trial

PCRonline @ ESC Congress 2024: the interventional cardiology perspective!

26 Jul 2024

What was new and hot in interventional cardiology at #ESCCongress 2024!

PCRonline @ ESC Congress 2024

The TRI.Fr trial: how will it impact my practice?

19 Jul 2024

Watch the replay of this webinar to get the main results from the TRI-FR trial, along with interventional and heart valve disease specialist interpretations based on the existing evidence!

Prognostic implications of residual tricuspid regurgitation grading after transcatheter tricuspid valve repair

18 Jun 2024

The take-home message for clinicians is that in the treatment of tricuspid regurgitation, the most frequent valvular disease alongside aortic stenosis, redefining procedural success as a function of the residual degree of TR is crucial.

Alessandro Sticchi

Reviewer

Alessandro Sticchi

Reviewer

Federico Bargagna
Prognostic implications of residual tricuspid regurgitation grading after transcatheter tricuspid valve repair

New York Valves 2024: Everything you need to know in a nutshell

11 Jun 2024

Alex Sticchi provides his take on the trials which were presented at New York Valves 2024, offering a concise summary, a short description and final thoughts. 

Alessandro Sticchi

Author

Alessandro Sticchi
New York Valves 2024: Everything you need to know in a nutshell

A journey through tricuspid regurgitation phenotypes

28 May 2024

Watch the replay of this webinar to learn about secondary tricuspid regurgitation (TR) and management of TR in patients with cardiac implantable electronic devices (CIED) and much more!

A journey through tricuspid regurgitation phenotypes